These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Disorders of the immune system in benign lesions and cancer of the breast].
    Author: Derevnina NA, Polevaia EB, Veskova TK, Trubcheninova LP, Bogatyrev VN.
    Journal: Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960.
    Abstract:
    Immunologic vigor was studied in 225 cases of breast cancer at various stages, 99 patients with benign lesions of the breast and 154 healthy donors. The parameters of cell-mediated immunity under study included total, active and neuraminidase T-lymphocyte levels, concentration of T-lymphocyte subsets (Tm, T gamma, theophylline--sensitive and theophylline--resistant) and their profile, functional activity of lymphocytes in blastogenic reaction with PHA and natural killer levels. Also, such humoral immunity indexes as B-lymphocytes and immunoglobulins A, M and C were evaluated. Significant changes in functional activity of the immune system (mainly, its T-cell--mediated component) were identified as early as at the initial stages of breast cancer development and they became more pronounced as tumor advanced. Also, at initial stages, both T-lymphocyte and natural killer functional activity started to flag.
    [Abstract] [Full Text] [Related] [New Search]